News

Pharmabiz1h
Amneal & Apiject to expand sterile and blow-fill-seal capabilities for advanced pharmaceutical manufacturing in US
Bridgewater, New Jersey Saturday, May 10, 2025, 15:00 Hrs [IST] ...
Pharmabiz2h
NIH study shows incidence rates of some cancer types have risen in people under age 50
Bethesda, Maryland Saturday, May 10, 2025, 14:00 Hrs [IST] ...
Pharmabiz22h
Pharma Quality Excellence Awards honour achievements of industry pioneers
The Pharma Quality Excellence Awards 2025 ceremony marked a significant milestone in recognizing outstanding contributions to ...
Pharmabiz3h
US FDA approves Verastem’s Avmapki Fakzynja combo therapy to treat patients with KRAS-mutated recurrent low-grade serous ovarian cancer
US FDA approves Verastem’s Avmapki Fakzynja combo therapy to treat patients with KRAS-mutated recurrent low-grade serous ovarian cancer: Boston Saturday, May 10, 2025, 13:00 Hrs ...
Pharmabiz4h
OmRx Oncology begins phase 2 trial of oral PD-L1 inhibitor OX-4224 in patients with non-small cell lung cancer
OmRx Oncology begins phase 2 trial of oral PD-L1 inhibitor OX-4224 in patients with non-small cell lung cancer: San Diego Saturday, May 10, 2025, 12:00 Hrs [IST] OmRx Oncology, or ...
Pharmabiz3h
Majority of micro and small units fails to apply for Schedule M timeline extension, says section of industry
Our Bureau, New Delhi Saturday, May 10, 2025, 12:30 Hrs [IST] ...
Pharmabiz7h
Asthma can be managed by medical treatment, lifestyle adjustments & environmental interventions: Dr Jakka
Asthma can be managed by medical treatment, lifestyle adjustments & environmental interventions: Dr Jakka: Shardul Nautiyal, Mumbai Saturday, May 10, 2025, 09:00 Hrs [IST] Despite ...
Pharmabiz5h
Johnson & Johnson expands efforts to champion the nursing workforce globally
Johnson & Johnson expands efforts to champion the nursing workforce globally: New Brunswick, New Jersey Saturday, May 10, 2025, 11:00 Hrs [IST] Johnson & Johnson announced the exp ...
Pharmabiz22h
Beacon Therapeutics announces phase 2 interim 6 months data from DAWN trial of Laru-zova
Beacon Therapeutics announces phase 2 interim 6 months data from DAWN trial of Laru-zova: London Friday, May 9, 2025, 18:00 Hrs [IST] Beacon Therapeutics Holdings Limited, a leadi ...
Pharmabiz8h
DGFT amends Standard Input Output Norms for DEP exports
In a significant policy shift aimed at optimizing raw material usage in pharma exports, the Directorate General of Foreign Trade (DGFT) has issued Public Notice amending the Standard Input Output ...
Pharmabiz8h
Telangana DCA seizes banned & expired drugs from corporate hospital pharmacies in statewide raids
Telangana DCA seizes banned & expired drugs from corporate hospital pharmacies in statewide raids: Peethaambaran Kunnathoor, Chennai Saturday, May 10, 2025, 08:00 Hrs [IST] Telang ...
Pharmabiz8h
DTAB asks manufacturers of ranitidine to monitor NDMA impurity and reduce shelf life
DTAB asks manufacturers of ranitidine to monitor NDMA impurity and reduce shelf life: Gireesh Babu, New Delhi Saturday, May 10, 2025, 08:00 Hrs [IST] The Drugs Technical Advisory ...